Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Oncologist
|
September 5, 2020
Professional Medical Writer Assistance in Oncology Clinical Trials
Ramez Kouzy, Joseph Abi Jaoude, Walker Mainwaring, et al.
JNCI Cancer Spectrum
|
November 23, 2020
Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials
Stephen R Grant, Timothy A Lin, Austin B Miller, et al.
Journal of the National Cancer Institute
|
June 6, 2019
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology
Ethan B Ludmir, Amit Jethanandani, Walker Mainwaring, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials
Dario Pasalic, C David Fuller, Walker Mainwaring, et al.
The Oncologist
|
April 10, 2020
Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials
Kelsey L Corrigan, Walker Mainwaring, Austin B Miller, et al.
Neuro-Oncology
|
January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trials
Roshal R Patel, Vivek Verma, Austin B Miller, et al.
JAMA Oncology
|
June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Oncologist
|
September 5, 2020
Professional Medical Writer Assistance in Oncology Clinical Trials
Ramez Kouzy, Joseph Abi Jaoude, Walker Mainwaring, et al.
JNCI Cancer Spectrum
|
November 23, 2020
Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials
Stephen R Grant, Timothy A Lin, Austin B Miller, et al.
Journal of the National Cancer Institute
|
June 6, 2019
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology
Ethan B Ludmir, Amit Jethanandani, Walker Mainwaring, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials
Dario Pasalic, C David Fuller, Walker Mainwaring, et al.
The Oncologist
|
April 10, 2020
Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials
Kelsey L Corrigan, Walker Mainwaring, Austin B Miller, et al.
Neuro-Oncology
|
January 5, 2020
Exclusion of patients with brain metastases from cancer clinical trials
Roshal R Patel, Vivek Verma, Austin B Miller, et al.
JAMA Oncology
|
June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute
|
July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial Participants
Ethan B Ludmir, C David Fuller, Shalini Moningi, et al.
Page
of 3